GemPharmatech is a fast-growing service center for production, distribution and phenotyping of gene-modified mouse models with multiple subsidiaries in China, and an upcoming one in the USA. Chairman Professor Xiang Gao discusses the company’s story, its ambitions in China and globally, its recent Series A financing round, and its close partnerships with the academic community, pharmaceutical companies and CROs around the world.
Our animal facility is the first one in China to earn AAALAC accreditation and has maintained it for 13 years. We adhere to strict international standards. Our mouse models are considered the healthiest and of best quality in China.
